FERRERI, ANNA MARIA
FERRERI, ANNA MARIA
ACRN - AREA DI CAMPUS DI RIMINI (attivo dal 14/05/2015 al 31/12/2018)
Personale esterno ed autonomi
Anti-invasive Effects and Proapoptotic Activity Induction by the Rexinoid IIF and Valproic Acid in Combination on Colon Cancer Cell Lines.
2012 A. Papi; A.M. Ferreri; F. Guerra; M. Orlandi
A Ligand of Retinoid X Receptor Overcome Multidrug Resistance in Human Colon Carcinoma LoVomdr Cell Line
2011 A. Papi; P. Rocchi; A. M. Ferreri; V. Arfilli; L. Bucci; M. Orlandi
Epigenetic Modifiers as Anticancer Drugs: Effectiveness of Valproic Acid in Neural Crest-derived Tumor Cells
2010 Papi A.; Ferreri A.M.; Rocchi P.; Guerra F.; Orlandi M.
RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells
2010 A.Papi; P.Rocchi; A.M. Ferreri; M. Orlandi
Enhanced effects of PPARγ ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.
2009 Papi A.; Rocchi P.; Ferreri A.M.; Guerra F.; Orlandi M
Growth inhibition and proapototic activity induction by the retinoid IIF and valproic acid on HT-29 colon cancer cell line
2009 Papi A; Ammar K; Rossi B; Rocchi P; Ferreri AM; Orlandi M
Growth Inhibition and Proapoptotic Activity Induction by IIF and Valproic Acid on RA-resistant Leukemia Cells.
2008 G.Bartolini;M.Orlandi;A.Papi;K.Ammar;R.Tonelli;M.Franzoni; A.Pession;P.Rocchi;A.M.Ferreri
ANTITUMORAL EFFECT OF RETINOIDS: A COMPARISON BETWEEN ALL TRANS RETINOIC ACID AND IIF, A SPECIFIC LIGAND OF RXR
2007 G.Bartolini; A.Papi; K.Ammar; A.M.Ferreri; P.Rocchi; M.Orlandi
Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in U87MG human glioblastoma cell line,
2007 Papi A; Bartolini G; Ammar K; Guerra F; Ferreri AM; Rocchi P; Orlandi M.
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator activated receptor-gamma
2006 A. Papi; M. Orlandi; M. Macciocca; P. Rocchi; A. Ferreri; K Ammar; G. Bartolini
Antitumoral effect of retinoids and ciglitazone on the melanoma cell line G361: key role of peroxisome proliferator-activated receptor gamma
2006 Papi A.;Orlandi M.; Rocchi P.; Ferreri Am.; Ammar K.; Bartolini G.
Search for multidrug resistance modulators: effects of retinoids in human colon carcinoma cells
2006 Bartolini G.; Orlandi M.; Papi A.; Ammar K.; Guerra F.; Ferreri A.; Rocchi P.
ANTITUMORAL EFFICACY OF RETINOIDS ON HUMAN MULTIDRUG RESISTANT COLON CARCINOMA (LOVO MDR) AND LEUKEMIA (HL60- MDR) CELL LINES
2005 G.Bartolini;A.M.Ferreri;P.Rocchi;A.Papi;M.Orlandi
EFFECTS OF RETINOIDS ON DRUG SENSITIVE AND MULTIDRUG RESISTANT HUMAN COLON CARCINOMA CELLS
2005 Bartolini G.; Orlandi M.; Ammar K.;Biasco G.;Papi A.; Ferreri A.M.; Rocchi P.
p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells
2005 P. Rocchi; R. Tonelli; C.Camerin; S.Purgato; R.Fronza; F.Bianucci; F.Guerra; A.Pession; AM.Ferreri
Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29
2004 BARTOLINI G.; AMMAR K.; MANTOVANI B.; SCANABISSI F.; FERRERI A.M.; ROCCHI P.; ORLANDI M.
Simple and dendritic cyclam derivative. Photophysical properties, effect of protonation and Zn++ coordination, preliminary screening as inhibitors of tumor cell growth
2004 SAUDAN C; CERONI P; VICINELLI V; BALZANI V; GORKA M; LEE S-K; VOGTLE F; ORLANDI M; BARTOLINI G.; TAVOLARI S; ROCCHI P; FERRERI AM
Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines
2000 Strippoli P.; Bagnara G.P.; Montanaro L.; Timeus F.; Ferreri A.M.; Rocchi P.